- Bright Minds
- https://brightmindsbio.com/
- Address: 90 Adelaide St W
- Location: Toronto, Ontario, Canada
User description
Bright Minds Biosciences focuses on creating the next generation of psychedelics to treat mental health disorders. Molecules that the world has never seen and that mother nature has not thought of. The company's altering the chemical structure in order to create psychedelics drugs with minimized side effects and improved therapeutic action.Latest listings
-
BMB-101: A Novel Therapeutic for Neuropsychiatric DisordersCheck with sellerHealth & Beauty Toronto (Ontario) November 21, 2024BMB-101 is an innovative drug under development by Bright Minds Biosciences, designed to selectively target the 5-HT2C serotonin receptor. By activating this receptor, BMB-101 aims to address a range of neuropsychiatric conditions, including depressi... -
How Bright Minds Embrace Investors With II Gen Psychedelics?Check with sellerOther Services Toronto (Ontario) August 12, 2022The COVID -19 pandemic along with the economic recession has already impacted the mental health of people all over the world. At the same time, these situations have led to the creation of new arising barriers among individuals who are already suffer... -
The History Of Psychedelic DrugsCheck with sellerOther Services Toronto (Ontario) August 6, 2021Before we get into a more detailed history of psychedelic drugs, let’s clarify what we mean by psychedelic. The term is commonly used to refer to any drugs that have a hallucinogenic effect. However, strictly speaking, it refers only to drugs that co... -
Naturally Occurring Psychoactive Substances that can TreatCheck with sellerOther Services Toronto (Ontario) August 6, 2021Psilocybin mushrooms, also known as magic mushrooms, are fungi that contain psilocybin, which is one of many psychedelics drugs. Psilocybin can have an effect on consciousness and has been used in therapeutic or religious contexts by Native Americans... -
Psychedelic Drugs Have Promising CapabilityCheck with sellerOther Services Toronto (Ontario) August 6, 2021The psychedelic stocks undeniably gaining momentum in this ever-transforming world. Even the current financial outcome of the company has been remarkable with quarter sales of around $7 million from just $0.2 million last year. Even high-profile exec... -
The Bright Minds Biotechnology Company Is EmergingCheck with sellerOther Services Toronto (Ontario) August 6, 2021The Bright Minds Bio is one such organization that is focusing on targeting the development of alternative 5-HT receptors that are providing greater therapeutic benefits with minimal risks. Another upside for this company is making an announcement of... -
The Bright Minds Bio Is Creating Modern Day PsychedelicsCheck with sellerOther Services Toronto (Ontario) July 30, 2021The psychedelic Drug Company is already having two of the patents globally to its advantage and its validity is up to the year 2036. At the same time, there is also the conduction of ongoing research that is occurring for securing the additional pate... -
Why Psychedelic Company Stocks Have Strong PositionCheck with sellerOther Services Toronto (Ontario) July 30, 2021The compound is known to cause some serious adversaries. The market opportunities for these potentially life-transforming medications could definitely be huge. The psychedelic company is already conducting the assessment of the efficacy of these medi... -
The Mental Health Crisis Has Worsened During Pandemic TimesCheck with sellerOther Services Toronto (Ontario) July 30, 2021The psychedelic drugs may, thus serves as pioneer in multibillion dollar mental health care industry. Due to this fast paced and enhanced level of researches on these compounds, it is clearly evident that it holds promising future in curing several t... -
The Bright Minds Bio Is Exploring Therapeutic ImpactsCheck with sellerOther Services Accord (Ontario) July 30, 2021In the coming times, there is a possibility that investors wishing to invest in the psychedelic companies stock Canada may witness strong growth as the form of commercializing the breakthrough therapeutic medications for the patients who have severe ...